Dasatinib-induced colitis in a patient with chronic myeloid leukaemia.

Dasatinib is a common treatment for chronic myeloid leukaemia with numerous side effects including gastrointestinal. We report a woman in her 50s who presented with haematochezia, weight loss and a positive faecal occult blood test. She was being treated for chronic myeloid leukaemia with dasatinib without the use of any concurrent medications, including non-steroidal anti-inflammatory drugs.

The Queensland Parkinson's Project: An Overview of 20 Years of Mortality from Parkinson's Disease.

Objective: The consensus is that life expectancy for individuals with Parkinson's disease (PD) is reduced, but estimations vary. We aimed to provide an overview of 20 years of mortality and risk factor data from the Queensland Parkinson's Project.

Methods: The analysis included 1,334 PD and 1,127 control participants.